现在的位置: 首页时讯速递, 进展交流>正文
[JAMA Surg发表论文]:私募股权收购医院中食道切除术的趋势与术后结局
2025年03月19日 时讯速递, 进展交流 [JAMA Surg发表论文]:私募股权收购医院中食道切除术的趋势与术后结局已关闭评论

Original Investigation 

January 2, 2025

Esophagectomy Trends and Postoperative Outcomes at Private Equity–Acquired Health Centers

Jonathan E. Williams, Sara L. Schaefer, Ryan C. Jacobs, et al

JAMA Surg. Published online January 2, 2025. doi:10.1001/jamasurg.2024.5920

Key Points

Question  How do postoperative outcomes following esophagectomy at private equity–acquired health centers compare with outcomes at nonacquired centers?

Findings  In this cohort study of 9462 patients who underwent esophagectomy (517 at private equity–acquired hospitals vs 8945 at nonacquired hospitals), those treated at private equity–acquired hospitals had significantly higher rates of 30-day mortality (8.1% vs 4.9%), any complications (36.6% vs 30.1%), serious complications (17.5% vs 14.3%), and failure to rescue (5.9% vs 3.4%).

Meaning  These findings suggest that structural characteristics of private equity–acquired health centers may contribute to poorer surgical outcomes in patients undergoing esophagectomy, motivating quality improvement efforts or care allocation for these patients.

Abstract

Importance  Growing trends in private equity acquisition of acute care hospitals in the US have motivated investigations into quality of care delivered at these health centers. While some studies have explored comparative outcomes for high-acuity medical conditions, care trends and outcomes of complex surgical procedures, such as esophagectomy, at private equity–acquired hospitals is unknown.

Objective  To compare structural characteristics and postoperative outcomes following esophagectomy between private equity–acquired and nonacquired health centers.

Design, Setting, and Participants  This retrospective cohort study included Medicare beneficiaries aged 65 to 99 years who underwent elective esophagectomy at US health centers between January 1, 2016, and December 31, 2020. Health centers were designated as private equity acquired using the Agency for Healthcare Research and Quality Compendium of US Health Systems. Data were analyzed between October 15, 2023, and March 30, 2024.

Exposure  Patient cohorts were created based on whether they received care at private equity–acquired or nonacquired health centers.

Main Outcomes and Measures  The main outcome was 30-day postoperative complications, mortality, failure to rescue, and readmission using summary statistics and multivariable logistic regression.

Results  A total of 9462 patients (mean [SD] age, 72.9 [5.6] years; 6970 male [73.7%]) underwent esophagectomy during the study period, with 517 (5.5%) receiving care at private equity–acquired institutions. Annual procedure volume was lower at private equity–acquired hospitals vs nonacquired hospitals (median, 2 [IQR, 1-4] vs 7 [IQR, 3-15] procedures per year). Compared with patients treated at nonacquired hospitals, patients treated at private equity–acquired hospitals had significantly higher 30-day mortality (8.1% [95% CI, 5.8%-10.3%] vs 4.9% [95% CI, 4.5%-5.3%]; odds ratio [OR], 1.82 [95% CI, 1.25-2.64]; P = .002), any complications (36.6% [95% CI, 32.9%-40.3%] vs 30.1% [95% CI, 29.2%-30.9%]; OR, 1.46 [95% CI, 1.18-1.80]), serious complications (17.5% [95% CI, 14.5%-20.6%] vs 14.3% [95% CI, 13.7%-15.0%]; OR, 1.34 [95% CI, 1.03-1.77]; P = .03), and failure to rescue (5.9% [95% CI, 3.9%-7.9%] vs 3.4% [95% CI, 3.1%-3.8%]; OR, 1.86 [95% CI, 1.22-2.84]; P = .004).

Conclusions and Relevance  These findings suggest that patients who undergo esophagectomy at private equity–acquired hospitals may be at risk for worse outcomes. Further understanding of the drivers of these outcomes is needed to improve performance and inform policy pertaining to care allocation for select surgical conditions.

抱歉!评论已关闭.

×
腾讯微博